Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism

被引:47
作者
Parks, Joan H.
Coe, Fredric L. [1 ]
Evan, Andrew P. [2 ]
Worcester, Elaine M.
机构
[1] Univ Chicago, Sch Med, Renal Sect, Dept Med, Chicago, IL 60637 USA
[2] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA
关键词
primary hyperparathyroidism; nephrolithiasis; hypercalciuria; hypercalcaemia; KIDNEY-STONES; PARATHYROID SURGERY; TUBULAR REABSORPTION; SENSING RECEPTOR; NEPHROLITHIASIS; DISEASE; HYPERCALCIURIA;
D O I
10.1111/j.1464-410X.2008.08064.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
To compare the clinical presentation, laboratory features and outcome of treatment in stone formers (SF) with primary hyperparathyroidism (HPT) to those without systemic disease. We compared 105 (54 female) stone-formers (SF) with primary hyperparathyroidism (HPT) to 2416 (835 female) common SF with no systemic disease, and 260 normal subjects (NS, 106 female) using pre-treatment and treatment data from our kidney-stone programme. All were assessed before treatment, with three 24-h urine samples, for stone risk factors, each with a corresponding fasting blood sample. Records were reviewed for stone rates and urological stone-related procedures. The hypercalcaemia of HPT was modest, but hypercalciuria was far more marked than in SF because the fractional calcium excretion of HPT exceeded that of SF. Surgical cure of HPT did not completely eradicate either hypercalciuria or hypophosphataemia, suggesting that these patients have some additional mineral disorder. Serum calcium and phosphate, and fractional excretion of calcium, combined into a discriminant function provided the best separation between HPT and SF. However, we present 49 patients for whom the diagnosis (HPT vs SF) has never been resolved, despite years of observation and successful reduction of stone recurrence. Stones in HPT have slightly more phosphate than SF but the difference is not large enough to be of clinical interest. The stone frequency in HPT is about that for SF, and treatment reduces stones in HPT and SF by about the same amount, 10 times. No study to date has compared HPT with SF and NS, as done here. SF with even slight hypercalcaemia and brisk hypercalciuria probably have this curable disease, and after cure clinicians must be wary of residual hypercalciuria that requires medical treatment. Some patients will never be fully diagnosed and remain, like ours, an enigma, albeit responsive to usual medical treatments. Although stones are modestly enriched with phosphate, most are mainly calcium oxalate, so the stone analysis is not clinically a guide to diagnosis.
引用
收藏
页码:670 / 678
页数:9
相关论文
共 25 条
  • [1] Kidney stone disease
    Coe, FL
    Evan, A
    Worcester, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (10) : 2598 - 2608
  • [2] Is there any connection between the presence of kidney stones in primary hyperparathyroidism and the location of an underlying adenoma?
    Csupor, E
    Toth, E
    Meszaros, S
    Ferencz, V
    Szucs, J
    Lakatos, P
    Horányi, J
    Perner, F
    Horvath, C
    [J]. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (05) : 257 - 261
  • [3] De Farias MLF, 1998, J BONE MINER RES, V13, P1679
  • [4] The cause of maintained hypercalciuria after the surgical cure of primary hyperparathyroidism is a defect in renal calcium reabsorption
    Farias, MLF
    Delgado, AG
    Rosenthal, D
    Vieira, JGH
    Kasamatsu, T
    Lazarevitch, MJ
    Pereira, MFC
    Lima, MB
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1996, 19 (01) : 12 - 20
  • [5] Primary hyperparathyroidism: Renal calcium excretion in patients with and without renal stone disease before and after parathyroidectomy
    Frokjaer, VG
    Mollerup, CL
    [J]. WORLD JOURNAL OF SURGERY, 2002, 26 (05) : 532 - 535
  • [6] GARDIN JP, 1984, MINER ELECTROL METAB, V10, P301
  • [7] HODGKINSON A, 1963, CLIN SCI, V25, P231
  • [8] JABBOUR N, 1991, SURG GYNECOL OBSTET, V172, P25
  • [9] 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis
    Kinoshita, Y
    Taguchi, M
    Takeshita, A
    Miura, D
    Tomikawa, S
    Takeuchi, Y
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (12) : 6727 - 6731
  • [10] RENAL TUBULAR REABSORPTION OF CALCIUM AND SODIUM IN PRIMARY HYPERPARATHYROIDISM
    KRISTIANSEN, JH
    BROCHNERMORTENSEN, J
    PEDERSEN, KO
    JENSEN, S
    GLUD, T
    [J]. ACTA ENDOCRINOLOGICA, 1990, 123 (02): : 194 - 202